Multiplexed Lateral Flow Assay Development: Benefits, Risks, and Strategies for Success in Infectious Diseases and Oncology

Join a 44-minute webinar led by Andre Alfaro, an experienced developer of in vitro diagnostic tests, exploring the complexities of multiplexed lateral flow assay development in infectious diseases and oncology. Discover the increasing diversity of lateral flow assay applications in the post-pandemic landscape, with a focus on multiplexing strategies to meet market demands and overcome technical limitations. Learn about essential benefits and potential risks of multiplexing, various development approaches, and common obstacles specific to infectious disease and oncology assays. Master strategies for optimizing multiplex assay performance and overcoming development challenges through practical insights drawn from extensive industry experience. Gain valuable knowledge about determining whether multiplexing is appropriate for specific products and how to anticipate potential development pitfalls. Participate in this educational session to earn PACE credits while expanding understanding of this critical diagnostic technology.